University Of Michigan Ann Arbor

In this episode, we talk to ACG presidents Mark Pochapin, MD, of NYU Langone, and David Greenwald, MD, of Mount Sinai, about the latest updates in COVID-19 for the gastroenterologist.   

Navigating physician burnout starts with recognizing that we are not immune to the mental health issues that plague our profession on a national level.

Many patients with MS turn to complementary treatment to help alleviate their symptoms. The National MS Society states that most patients in the United States incorporate complementary treatment as part of their disease management.

Jami Kinnucan, MD, assistant professor at the University of Michigan, spoke with Healio about cannabis use among patients with ulcerative colitis and Crohn’s disease, the impact of diet on IBD management and the overall role of complementary therapy in the GI field, specifically for patients with IBD.

ORLANDO — In this video, Matthew Pianko, MD, clinical assistant professor of internal medicine at the University of Michigan’s Rogel Cancer Center, discusses a late breaking abstract on the “exciting” CANDOR study presented the ASH Annual Meeting and Exposition.

ORLANDO — ASH named three Choosing Wisely Champions today at its Annual Meeting and Exposition, recognizing clinicians who have implemented projects to improve quality and reduce costs at their institutions.

ORLANDO — The addition of aspirin to direct oral anticoagulant therapy for venous thromboembolism or nonvalvular atrial fibrillation appeared associated with increased rates of bleeding events compared with use of the anticoagulants alone, according to results of a registry-based cohort study presented at ASH Annual Meeting at Exposition.

The San Antonio Breast Cancer Symposium and American Association for Cancer Research — one of the conference’s co-sponsors — will recognize two researchers at this year’s meeting.

Oncologists, and physicians in general, are trained to strive for excellence, remain strong and resilient in the most difficult circumstances, and devote themselves to the patients who depend on them.

Patients with thyroid cancer who opt for maximal vs. minimal surveillance after being declared disease-free consume a greater amount of health care resources without clear evidence of improved outcomes, according to results of a retrospective study published in Cancer.